Velicept Therapeutics, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Velicept Therapeutics, Inc..The latest application filed is for "solabegron zwitterion and uses thereof".

Company Profile

12.17.16

Velicept Therapeutics, Inc. - Wayne PA US
VELICEPT THERAPEUTICS, INC. - Malvern PA US
VELICEPT THERAPEUTICS, INC. - Malvem PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solabegron Zwitterion And Uses Thereof App 20210317073 - STEVENS; Raymond E. ; et al.	2021-10-14
Solabegron zwitterion and uses thereof Grant 10,844,004 - Stevens , et al. November 24, 2	2020-11-24
Compositions and methods of using modified release solabegron for lower urinary tract symptoms Grant 10,751,311 - Ohlstein , et al. A	2020-08-25
Pharmaceutical Compositions And The Treatment Of Overactive Bladder App 20200246292 - Kind Code	2020-08-06
Pharmaceutical compositions and the treatment of overactive bladder Grant 10,668,034 - Caltabiano , et al.	2020-06-02
Pharmaceutical Compositions And The Treatment Of Overactive Bladder App 20190365683 - Caltabiano; Stephen ; et al.	2019-12-05
Pharmaceutical compositions and the treatment of overactive bladder Grant 10,350,182 - Caltabiano , et al. July 16, 2	2019-07-16
Solabegron Zwitterion And Uses Thereof App 20190185414 - STEVENS; Raymond E. ; et al.	2019-06-20
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms App 20190083434 - OHLSTEIN; Eliot ; et al.	2019-03-21
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms App 20190083433 - OHLSTEIN; Eliot ; et al.	2019-03-21
Solabegron zwitterion and uses thereof Grant 10,221,126 - Stevens , et al.	2019-03-05
Solabegron Zwitterion And Uses Thereof App 20180370902 - STEVENS; Raymond E. ; et al.	2018-12-27
Solabegron zwitterion and uses thereof Grant 10,065,922 - Stevens , et al. September 4, 2	2018-09-04
Pharmaceutical Compositions And The Treatment Of Overactive Bladder App 20180147169 - CALTABIANO; Stephen ; et al.	2018-05-31
Compositions and methods of using modified release solabegron for lower urinary tract symptoms Grant 9,956,194 - Ohlstein , et al. May 1, 2	2018-05-01
Pharmaceutical compositions and the treatment of overactive bladder Grant 9,907,767 - Caltabiano , et al. March 6, 2	2018-03-06
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms App 20170348263 - OHLSTEIN; Eliot ; et al.	2017-12-07
Dosing Regimens For Beta-3 Adrenoceptor Agonists And Anti-muscarinic Agents For The Treatment And Prevention Of Lower Urinary Tract Symptoms And Overactive Bladder App 20170348288 - OHLSTEIN; Eliot ; et al.	2017-12-07
Pharmaceutical Compositions And The Treatment Of Overactive Bladder App 20170151199 - CALTABIANO; Stephen ; et al.	2017-06-01
Solabegron Zwitterion and Uses Thereof App 20170114005 - STEVENS; Raymond E. ; et al.	2017-04-27
Method Of Using Solabegron App 20170035716 - OHLSTEIN; Eliot	2017-02-09
Pharmaceutical Combination Grant 9,522,129 - Caltabiano , et al. December 20, 2	2016-12-20
Compositions And Methods Of Using Modified Release Solabegron For Lower Urinary Tract Symptoms App 20160158176 - OHLSTEIN; Eliot ; et al.	2016-06-09

Company Registrations

SEC

0001659819

Velicept Therapeutics, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.